Evidence map›Paper›PMID 35351229›Full record

ArticleEuropean psychiatry : the journal of the Association of European Psychiatrists2022

Cost-utility analysis of rTMS as add-on therapy to standard care for the treatment of hallucinations in schizophrenia.

Lauren Hendriks, Cathrine Mihalopoulos, Long Khanh-Dao Le, Colleen Loo, Mary Lou Chatterton

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European psychiatry : the journal of the Association of European Psychiatrists, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Guideline
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Lauren HendriksDeakin University, Geelong, Victoria, Deakin Health Economics, Institute for Health Transformation, Australia.ORCID https://orcid.org/0000-0001-9189-2232
Cathrine MihalopoulosDeakin University, Geelong, Victoria, Deakin Health Economics, Institute for Health Transformation, Australia.ORCID https://orcid.org/0000-0002-7127-9462
Long Khanh-Dao LeDeakin University, Geelong, Victoria, Deakin Health Economics, Institute for Health Transformation, Australia.ORCID https://orcid.org/0000-0002-9442-6824
Colleen LooUniversity of New South Wales.ORCID https://orcid.org/0000-0003-3267-0554
Mary Lou ChattertonDeakin University, Geelong, Victoria, Deakin Health Economics, Institute for Health Transformation, Australia.ORCID https://orcid.org/0000-0003-4902-9448
Deakin University · AUUNSW Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cost-utility analysisdisability adjusted life yearsRepetitive transcranial magnetic stimulationSchizophrenia

Identifiers

PMID35351229
PMCPMC9058442
OpenAlexW4221103697

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.